BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 38610001)

  • 1. Nicotine-induced activation of cholinergic receptor nicotinic alpha 5 subunit mediates the malignant behaviours of laryngeal squamous epithelial cells by interacting with RABL6.
    Shen Y; Huang Q; Yuan X; Gong H; Xu C; Du H; Hsueh CY; Zhou L
    Cell Death Discov; 2024 Jun; 10(1):286. PubMed ID: 38879667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RUNX1-BMP2 promotes vasculogenic mimicry in laryngeal squamous cell carcinoma via activation of the PI3K-AKT signaling pathway.
    Zhu Q; Zhang X; Lu F; Miao S; Zhang C; Liu Z; Gao Z; Qi M; An X; Geng P; Wang S; Ren H; Han F; Zhang R; Zha D
    Cell Commun Signal; 2024 Apr; 22(1):227. PubMed ID: 38610001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircCDK1 blocking IGF2BP2-mediated m6A modification of CPPED1 promotes laryngeal squamous cell carcinoma metastasis via the PI3K/AKT signal pathway.
    Li J; Cao H; Yang J; Wang B
    Gene; 2023 Oct; 884():147686. PubMed ID: 37543219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vasculogenic mimicry in laryngeal squamous cell carcinoma and its clinicopathological significance].
    Wu S; Yu L; Zhou L; Cheng Z; Wang D
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2014 Aug; 31(4):865-9. PubMed ID: 25464804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non‑coding RNA fer‑1‑like family member 4 serves as a tumor suppressor in laryngeal squamous cell carcinoma cells via regulating the AKT/ERK signaling pathway.
    Jiao L; Liu S; Liu L; Hao P; Gong Z; Yan Z; Xiang Y
    Mol Med Rep; 2020 Dec; 22(6):5304-5312. PubMed ID: 33174027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF2BP2-m6A-circMMP9 axis recruits ETS1 to promote TRIM59 transcription in laryngeal squamous cell carcinoma.
    Li J; Cao H; Yang J; Wang B
    Sci Rep; 2024 Feb; 14(1):3014. PubMed ID: 38321126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of vasculogenic mimicry and endothelium-dependent vessel in metastasis of laryngeal cancer].
    Wang W; Lin P; Sun BC; Cai WJ; Han CR; Li L; Lu HH; Zhang JM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 May; 47(5):400-5. PubMed ID: 22883583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cuproptosis-related LINC02454 as a biomarker for laryngeal squamous cell carcinoma based on a novel risk model and in vitro and in vivo analyses.
    Zhu Q; Zhang R; Lu F; Zhang X; Zhang D; Zhang Y; Chen E; Han F; Zha D
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):15185-15206. PubMed ID: 37639011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RUNX1 and cancer.
    Lin TC
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188715. PubMed ID: 35271994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic protein induces bone invasion of melanoma by epithelial-mesenchymal transition via the Smad1/5 signaling pathway.
    Gao J; Muroya R; Huang F; Nagata K; Shin M; Nagano R; Tajiri Y; Fujii S; Yamaza T; Aoki K; Tamura Y; Inoue M; Chishaki S; Kukita T; Okabe K; Matsuda M; Mori Y; Kiyoshima T; Jimi E
    Lab Invest; 2021 Nov; 101(11):1475-1483. PubMed ID: 34504305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Chk2-PKM2 axis promotes metabolic control of vasculogenic mimicry formation in p53-mutated triple-negative breast cancer.
    Yu P; Zhu X; Zhu JL; Han YB; Zhang H; Zhou X; Yang L; Xia YZ; Zhang C; Kong LY
    Oncogene; 2021 Aug; 40(34):5262-5274. PubMed ID: 34244606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer.
    Yu L; Wei J; Liu P
    Semin Cancer Biol; 2022 Oct; 85():69-94. PubMed ID: 34175443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasculogenic mimicry, a complex and devious process favoring tumorigenesis - Interest in making it a therapeutic target.
    Treps L; Faure S; Clere N
    Pharmacol Ther; 2021 Jul; 223():107805. PubMed ID: 33465401
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.